Home » Newsletters » BioWorld Science

BioWorld Science

March 13, 2001

View Archived Issues

Atrix/Elan joint venture begins development of antiemetic product

ASCPT news: GW-320659 has favorable PK and drug interaction profile in man

Pharmacokinetics and pharmacodynamics of GI-262570 alone and in combination

De Novo and Organon establish drug design and discovery alliance

Bavarian Nordic reports good progress on development projects

Durect accelerates development of DUROS pain product

Karo Bio and Bristol-Myers Squibb extend and expand drug discovery alliance for metabolic disorders

Athersys and the Cleveland Clinic Foundation enter drug discovery collaboration

Antiapoptotic protein identified; antisense construct induces apoptosis in cancer cells

Emisphere begins phase I evaluation of heparin tablets with SNAD delivery system

German study demonstrates inhibition of LDL-induced VSMC growth for thiazolidinediones

AxyS Pharmaceuticals updates development programs

Lion's acquisition of Trega Biosciences imminent

Single-injection thrombolytic introduced in the E.U.

Sepracor submits norastemizole NDA for treatment of allergic rhinitis

Plant extract acts as a selective estrogen receptor modulator (SERM) according to DGE presentation

Inhibition of iNOS as a therapeutic approach to inflammatory bowel disease

Noncompetitive HIV-1 protease inhibitor isolated from extremophilic microorganism

Renal function improves upon replacement of calcineurin inhibitors with mycophenolate mofetil

Gene therapies for vascular proliferative diseases

Human obesity-related peptide discovered at Knoll

Polypeptide with utility in preventing, diagnosing and treating osteoporosis

Merck KGaA identifies new series of integrin inhibitors

Caspase inhibitors specifically claimed by Merck for Alzheimer's disease

New inhibitors of Ras prenylation in the Merck pipeline

Synthesis and therapeutic use of neuropeptide antagonists described by AstraZeneca

Telomerase-inhibitory carboxamides and use in cancer, psoriasis, etc.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...